文献速递心律失常心力衰竭与心肌病

非扩张型左室心肌病主要心律失常事件的新型预测评分

Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score.
PubMed 文献 · Eur Heart J · 2026-01-01

在337例无主要心律失常事件(MAE)史的非扩张型左室心肌病(NDLVC)患者中,回顾性识别并随访60个月,51例(15%)发生首次MAE;男性、非持续性室速、LVEF<45%、间隔及环状LGE、高危基因变异和心肌炎症为独立预测因子,衍生风险评分在216例外部验证队列中C-index为0.81。

要点

  • NDLVC患者60个月MAE发生率为15%。
  • 心肌炎症预测MAE的HR达15.7(95%CI 6.1-40.3)。
  • LVEF<45%预测MAE的HR为5.5(95%CI 2.7-11.0)。

核心结论

  • 在NDLVC患者中,男性、非持续性室速、LVEF<45%、间隔及环状LGE、指南定义的高危基因致病/可能致病变异及心肌炎症可预测60个月内首次MAE。

研究设计与样本

  • 回顾性识别两个大型中心337例无MAE史的NDLVC患者,诊断评估包括心脏磁共振(CMR)、心内膜心肌活检和基因检测,主要终点为60个月随访内首次MAE(持续性室速、心室颤动或适当ICD治疗)。
  • 验证队列为来自11个欧洲中心的216例NDLVC患者。

主要发现

  • 研究队列平均年龄37±15岁,男性占62%,平均LVEF 52±8%,79%患者基线CMR存在晚期钆增强(LGE)。
  • 60个月随访内51例(15%)发生MAE。
  • 男性HR 2.4(95%CI 1.3-4.4,P=.007),基线非持续性室速HR 3.1(95%CI 1.7-5.6,P<.001),LVEF<45% HR 5.5(95%CI 2.7-11.0,P<.001)。

关键数值与推荐

  • MAE定义:持续性室速、心室颤动或适当ICD治疗。
  • 高危基因定义:指南定义的高危基因致病/可能致病变异。
  • 心肌炎症定义:活检或CMR证实。

临床怎么用

  • 对NDLVC患者应评估男性、非持续性室速、LVEF<45%、间隔及环状LGE、高危基因变异及心肌炎症以预测60个月内首次MAE。
  • 新型风险评分可用于NDLVC患者首次MAE的风险分层。

局限性

  • 回顾性研究设计。
  • 环状LGE预测MAE的HR无统计学显著性(P=.54)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The prediction of the first major arrhythmic event (MAE) is still an unmet need in the recently defined scenario of non-dilated left ventricular cardiomyopathy (NDLVC). METHODS: A cohort of 337 patients with NDLVC and no history of MAE was retrospectively identified at two large centres. Patient-tailored diagnostic workup included cardiac magnetic resonance (CMR), endomyocardial biopsy, and genetic testing. The primary endpoint was the occurrence of the first MAE, including sustained ventricular tachycardia (VT), ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy, by 60-month follow-up. A pool of 216 NDLVC patients from 11 European centres served as a validation cohort. RESULTS: In the study cohort (mean age 37 ± 15 years, 62% male), the mean left ventricular ejection fraction (LVEF) was 52 ± 8%, and 79% of patients had late gadolinium enhancement (LGE) at baseline CMR. By 60-month follow-up, 51 patients (15%) experienced a MAE. The primary endpoint was predicted by male sex [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.3-4.4, P = .007], baseline non-sustained VT (HR 3.1, 95% CI 1.7-5.6, P < .001), LVEF < 45% (HR 5.5, 95% CI 2.7-11.0, P < .001), septal (HR 2.0, 95% CI 1.0-4.0, P = .046) and ring-like pattern of LGE (HR 1.3, 95% CI .6-2.6, P = .54), pathogenic/likely pathogenic variants in guideline-defined high-risk genes (HR 4.6, 95% CI 2.3-9.1, P < .001), and biopsy/CMR-proven myocardial inflammation (HR 15.7, 95% CI 6.1-40.3, P < .001). The results were confirmed in the validation cohort (Uno's C-index 0.81, 95% CI .75-.88). A novel risk score was subsequently derived. CONCLUSIONS: In NDLVC, male sex, non-sustained VT, LVEF < 45%, septal and ring-like LGE, high-risk genotypes, and myocardial inflammation predicted the first episode of MAE by 60 months.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Peretto G, Merlo M, Ambrosi A, et al. Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score. Eur Heart J. 2026. PMID: 40678978. doi:10.1093/eurheartj/ehaf477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。